♟️ Wednesday 4 March 2026 Wed, 4 Mar 2026
10 Move Signals
NSW Greenlights Dartbrook Mine Life Extension Amid Financial Turmoil
The NSW Department of Planning and Environment has approved a six-year extension for the Dartbrook underground coal mine, pushing its operational horizon to 2033 despite ongoing financial administration challenges.
4 Mar
Maxwell Dee
Pure Foods Tasmania Turns Corner with Elato Acquisition and National Expansion
Pure Foods Tasmania reports a significant operational turnaround in 1H FY26, driven by strategic cost reductions, expanded distribution deals with major retailers, and the acquisition of premium ice cream brand Elato.
4 Mar
Victor Sage
OD6 Metals Eyes US Fluorspar Supply with High-Grade Nevada Acquisition
OD6 Metals has secured an exclusive option to acquire the Quinn Fluorspar Project in Nevada, boasting ultra high-grade deposits critical to US supply chains. The move complements its rare earth and copper assets, backed by a $3.4 million capital raise.
4 Mar
Maxwell Dee
AKORA Secures 25-Year Mining Permit, Accelerating Bekisopa Iron Ore Development
AKORA Resources has secured a 25-year mining permit for its high-grade Bekisopa iron ore project in Madagascar, marking a pivotal step from exploration to development and unlocking new financing and partnership opportunities.
4 Mar
Maxwell Dee
Cue Energy Faces Horizon Oil Takeover Bid: What’s Next for Shareholders?
Horizon Oil has launched an off-market takeover offer for Cue Energy Resources, proposing a mix of cash and shares. Cue’s Independent Board Committee is now carefully evaluating the proposal before advising shareholders.
4 Mar
Maxwell Dee
Brightstar Secures US$120M Bond to Fully Fund Goldfields Project
Brightstar Resources has completed a US$120 million senior secured bond issue, complementing a recent A$193 million equity raise, to fully fund its Goldfields Project and advance the Sandstone Project towards final investment decision.
4 Mar
Maxwell Dee
Island Pharmaceuticals Joins Forces with USAMRIID to Fast-Track Marburg Virus Drug
Island Pharmaceuticals has entered a pivotal research agreement with USAMRIID and the Geneva Foundation to accelerate FDA approval of Galidesivir for Marburg Virus Disease, leveraging top-tier US biodefense expertise.
4 Mar
Victor Sage
Cobalt Blue Hits Key Milestone with High-Purity Cobalt Sulphate for Battery Market
Cobalt Blue Holdings has confirmed its cobalt sulphate meets stringent battery precursor specifications, advancing its Kwinana Cobalt Refinery toward a Final Investment Decision. The company also expands its graphite recovery program, positioning itself at the forefront of Australia’s battery materials ecosystem.
4 Mar
Maxwell Dee
Straker Unveils Co-CEO Duo to Accelerate AI-Driven Growth
Straker Ltd announces a pivotal leadership shift with the appointment of David Sowerby and Indiver Nagpal as Co-CEOs, marking a new era focused on commercial expansion and AI innovation. Founder Grant Straker transitions to a strategic board role to steer the company’s AI future.
4 Mar
Sophie Babbage
Endeavour Group H1 F26: EBIT $563M, Retail Gains, Hotels Drive Growth Amid Rising Capex
Endeavour Group reported a solid first half for fiscal 2026 with underlying EBIT of $563 million, supported by retail price leadership and strong hotel sales growth. The group raised capital expenditure guidance, reflecting accelerated hotel renewals and strategic investments.
4 Mar
Victor Sage